Peer Review History
| Original SubmissionOctober 10, 2025 |
|---|
|
-->PONE-D-25-54696-->-->Elevation and Land Use Shape Soil Entomopathogenic Fungal Communities in the Uluguru Mountains, Tanzania-->-->PLOS One Dear Dr. Mussa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 11 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ebrahim Shokoohi Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Thank you for stating in your Funding Statement: [This work was supported by the Sokoine University of Agriculture (SUA) internal research fund (Grant No. SUA/2024/AGROBIO/EPF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.]. Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 4. Thank you for stating the following in your manuscript: [This work was supported by the Sokoine University of Agriculture (SUA) internal research fund (Grant No. SUA/2024/AGROBIO/EPF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.] We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [This work was supported by the Sokoine University of Agriculture (SUA) internal research fund (Grant No. SUA/2024/AGROBIO/EPF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.] Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. Please upload a new copy of Figure 7 as the detail is not clear. Please follow the link for more information: https://journals.plos.org/plosone/s/figures 6. We note that Figure 1 in your submission contains map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: 1. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” 2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: General Assessment: The manuscript addresses an important topic—the diversity and distribution of soil-borne entomopathogenic fungi (EPFs) along elevational and land-use gradients in a biodiversity hotspot. The integration of amplicon-based metagenomics with culture-based isolation and pathogenicity assays is commendable, providing both ecological and applied perspectives. The study is well-structured, with clear hypotheses, a thorough introduction, and relevant discussion that situates the findings in a global context. However, while the manuscript has significant merit, several issues limit its impact and reproducibility. Key concerns relate to methodological clarity, statistical robustness, phylogenetic analysis, and interpretation of results. Specific comments follow. 1. Title and Abstract: a) The title accurately reflects the study focus. Consider including “metagenomic and culture-based approaches” to highlight methodological novelty. b) Abstract is concise and informative, but it overstates significance in places. For example, claims about “versatile taxa offering locally adapted candidates for biological control” should be tempered, as pathogenicity data are preliminary and limited to lab assays. 2. Introduction: a) Well-written with extensive literature coverage. The authors effectively justify the need to study EPF diversity along elevation and land-use gradients in Africa, specifically Tanzania. b) Minor suggestion: The introduction occasionally overgeneralizes (“EPFs regulate more than 700 insect pests”) without specifying context (laboratory vs field). Consider clarifying. c) The hypotheses are clear, but the expectation that fallow soils will always have higher diversity is not consistently supported in literature; the authors do acknowledge this later in discussion. 3. Materials and Methods: a) Sampling Design: Sampling is clearly described. The use of 24 soil samples is modest; this limits statistical power, especially for PERMANOVA (p ≈ 0.06). Consider discussing this limitation explicitly. b) Metagenomic Analysis: 1. ITS1-ITS2 region amplification is standard. 2. Quality control is thorough; however, the method for OTU clustering or ASV inference is not explicitly stated. Was DADA2, QIIME2, or another pipeline used? This is critical for reproducibility. 3. It is unclear how reads were assigned to EPF taxa. Were custom reference databases used for entomopathogenic fungi, or were general ITS databases applied? Misclassification of fungi is common in general ITS databases. c) Culture-Based Isolation: Clear and methodical; semi-selective media and serial dilutions are appropriate. d) Pathogenicity Assays: 1. Larval bioassays are well-described. However, only 10 larvae per replicate (n=3) is a small sample size for mortality estimation, reducing statistical confidence. Consider larger replicates or a more robust statistical analysis. 2. Mortality range (10–50%) is broad; authors should clarify if variability is due to isolate differences or experimental conditions. e) Phylogenetic Analysis: 1. ITS-based phylogenies are acceptable for genus-level identification but have limited resolution at species level, especially for Metarhizium and Purpureocillium. 2. Bootstrap values or support metrics in Fig. 7 are not discussed. Many entomopathogenic fungi require multi-locus markers (TEF1, RPB1/2) to resolve cryptic species; the manuscript should acknowledge this limitation. In phylogenetic trees it must be only accession numbers and species name. All underlined, “.1” and additional signs must be removed and present the figure at standard level. 4. Results: • Diversity Analyses: 1. Alpha diversity is reported with multiple indices. The text occasionally overinterprets non-significant trends. For example, PERMANOVA results (p = 0.063) are not statistically significant; claims about land-use shaping communities should be tempered. 2. Figures are informative, but some heatmaps and PCoA plots could benefit from clearer labeling (e.g., symbols for elevation, colors for land-use). • Community Composition: 1. Observation of “hump-shaped” diversity at medium elevation is interesting, but limited replication and low sample size may affect robustness. 2. Relative abundance discussion is clear but could be supported with formal statistical testing (e.g., differential abundance analysis using DESeq2 or ANCOM). • Pathogenicity and Cultivable Isolates: 1. P. lilacinum and C. rosea show moderate virulence. The discussion rightly emphasizes ecological plasticity. However, the small-scale lab assay cannot directly support field-level pest management recommendations. 5. Discussion: a) Discussion is comprehensive, integrating results with global studies. b) Authors appropriately highlight that cultivation may enhance EPF diversity in certain contexts, contrasting with other studies. c) Limitations are partially addressed (small sample size, single season), but should also include: 1. ITS marker resolution limits for cryptic species identification. 2. Low number of biological replicates in pathogenicity assays. 3. Lack of direct link between soil chemistry/host density and EPF occurrence. d) Some statements about ecological implications (e.g., “medium elevation zones are biodiversity hotspots”) are plausible but need cautious phrasing given limited data. 6. Figures and Tables: a) Figures are generally clear; PCoA and heatmaps are informative. b) Phylogenetic tree (Fig. 7) could be improved: 1. Include bootstrap values for all major nodes. 2. Label sequences with accession numbers to ensure reproducibility. 3. Consider adding an outgroup to properly root trees. c) Tables are detailed. Table 3 could report standard deviation of larval mortality to better illustrate variability. 7. References: a) Literature coverage is thorough and up-to-date. b) Minor formatting inconsistencies observed (e.g., journal names, DOI formatting). 8. Ethical Considerations and Data Availability: a) Ethical statement is appropriate; verbal consent for soil sampling is acceptable. b) Public deposition of sequencing reads is commendable; consider including BioProject ID or direct SRA link in the main text. 9. Overall Strengths: a) Integrated metagenomics and culture-based approach. b) Comprehensive ecological interpretation. c) Relevance for local agroecological management. d) Clear writing and logical structure. 10. Major Concerns / Recommendations: 1. Statistical robustness: Emphasize that PERMANOVA results were non-significant; avoid overinterpreting trends. 2. Phylogenetic analysis: ITS alone may not resolve species-level relationships; clarify limitations and consider multi-locus approaches for future studies. 3. Sample size: 24 soil samples and small larval bioassays limit power; acknowledge in discussion. 4. Claims about biocontrol potential: Moderate lab-based mortality should not be interpreted as field efficacy; temper wording. 5. Methodological clarity: Provide OTU/ASV processing pipeline and reference databases. 11. Minor Suggestions: a) Correct spelling of “Purpureocillim” → “Purpureocillium” in multiple places. b) Improve figure labeling for clarity (colors, symbols, axis labels). c) Include standard deviations or error bars for mortality assays. d) Clarify whether fallow soils were recently abandoned or long-term fallows, as this affects fungal diversity. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Yes Reviewer #2: Yes ********** -->2. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: Yes Reviewer #2: No ********** -->3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: Yes ********** -->4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: Yes ********** -->5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: General Assessment The manuscript presents a comprehensive investigation into how elevation and land-use gradients shape the diversity and distribution of soil-borne entomopathogenic fungi (EPFs) in the Uluguru Mountains, Tanzania. The study employs a robust combination of amplicon-based high-throughput sequencing, culture-based isolation, and pathogenicity bioassays to provide valuable ecological and applied insights. The objectives are well defined, the methodology is rigorous, and the discussion effectively links findings to previous global and regional studies. Overall, the manuscript is of high quality and original within its regional context. While the study is scientifically rigorous and methodologically sound, I suggest that the following few minor issues and suggestions should be addressed to improve clarity, statistical interpretation, and reference consistency. In addition, I also recommend some minor editorial and formatting adjustments to enhance readability, language precision, and figure labeling. In conclusion, this paper merits acceptance after the indicated minor revision, as it provides valuable baseline information for tropical fungal ecology, integrated pest management, and sustainable agricultural systems. Minor Issues and Suggestions 1) The abstract is well written, though including the number of soil samples (n = 24) in the Methods section of the abstract would provide immediate clarity. 2) In the data analysis section, ensure consistent reporting of software packages with version numbers (e.g., vegan, ggplot2, MEGA v12), and cite their corresponding references. 3) In the results, the PERMANOVA finding (p = 0.06) should be described as a marginal trend and discussed in terms of ecological rather than strict statistical significance. Verify that all figures and tables (1–7) are cited in sequence and that each caption is descriptive and self-contained. 4) Minor grammatical improvements are needed to simplify some sentences and remove redundancy—for example, replacing “This study investigated” with “This study assessed.” 5) Ensure references conform to PLOS ONE style by writing full journal names and including DOIs; check for duplicate or incomplete entries, such as references 14 and 35. 6) The discussion could be further strengthened by briefly relating the observed diversity patterns to possible soil physicochemical factors such as organic matter content, pH, or moisture gradients. Minor Editorial and Formatting Notes 1) Scientific names such as Metarhizium anisopliae and Clonostachys rosea should be italicized consistently. 2) Numerical formatting should follow scientific conventions, for example 1 × 10⁸ conidia mL⁻¹. 3) Replace approximate p-values (“p≈0.06”) with standard notation (“p = 0.06”) and ensure consistent use of hyphens and en-dashes. Conclusion and Recommendation In conclusion, the manuscript represents a well-designed, data-rich, and regionally important contribution to fungal ecology and biological control research. The work demonstrates that both elevation and land use significantly shape soil EPF communities and highlights promising native taxa for sustainable pest management. Given the sound methodology, clear data presentation, and valuable ecological insight, I recommend acceptance after the above minor indicated revision. Reviewer #2: Dear Authors I have checked the maniscript. The manuscript addresses a relevant topic and combines ITS metabarcoding, culture-based isolation, and preliminary pathogenicity assays, which is a clear strength. The study fits the scope of PLOS ONE; however, several conclusions are stronger than supported by the data. Key Concerns Low sample size (n = 24) limits statistical power; most diversity metrics and PERMANOVA results are not statistically significant (p ≈ 0.06). Despite this, the manuscript uses strong causal language (e.g., “significantly shaped”), which should be softened. Pathogenicity assays are preliminary, and biocontrol claims should be stated cautiously. Limitations of ITS-based species resolution, particularly for Metarhizium and related taxa, should be explicitly acknowledged. Strengths Addresses a clear knowledge gap in East African agroecosystems Integrates molecular and culture-based approaches Data availability and ethical compliance meet journal requirements With more cautious interpretation of non-significant results and clearer acknowledgment of methodological limitations, the manuscript would be suitable for publication in PLOS ONE. ********** -->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: Yes: Lawan Adamu Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
-->PONE-D-25-54696R1-->-->Elevation and land use shape soil entomopathogenic fungal communities in the Uluguru mountains, Tanzania: Insights from metagenomic and culture-based approaches-->-->PLOS One Dear Dr. Mussa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.-->--> Please submit your revised manuscript by May 09 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
--> If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Ebrahim Shokoohi Academic Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments : Dear Authors Please check the comments by the referee, which include minor changes still needed for your manuscript. Kind regards, [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--> Reviewer #2: All comments have been addressed ********** -->2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #2: Yes ********** -->3. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #2: Yes ********** -->4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #2: Yes ********** -->5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #2: Yes ********** -->6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #2: Dear Authors, I would like to thank the authors for their careful and thorough revision of the manuscript. The revised version shows clear improvement in methodological clarity, statistical interpretation, and overall presentation. In particular, the authors have successfully addressed most of the major concerns raised in the previous review. The clarification of sequencing workflow, improvement of statistical interpretation (especially regarding PERMANOVA), inclusion of data availability information, and the more cautious interpretation of pathogenicity results have significantly strengthened the manuscript. In my opinion, the manuscript is now suitable for publication in its current form. I only have a few minor suggestions that could further improve clarity and robustness, but these can be addressed at the authors’ discretion or considered in future studies. Minor comments and suggestions: Bioinformatics approach While the use of CZ ID for taxonomic classification is clearly described, it would be helpful if the authors briefly acknowledge in the discussion that the absence of ASV/OTU-based inference may influence fine-scale diversity estimates. This clarification would strengthen transparency but does not affect the overall conclusions. Interpretation of diversity patterns The observation that cultivated soils sometimes show higher diversity than fallow soils is interesting. A short note emphasizing that this pattern may be context-dependent (e.g., influenced by local agricultural practices or soil properties) would improve interpretation. Pathogenicity assay The authors have appropriately described these experiments as preliminary. For clarity, they may briefly mention in the discussion that future studies could include dose-response assays and larger sample sizes to better quantify virulence. Minor technical corrections Check for minor typographical issues (e.g., “OUT” vs “OTU”) Ensure consistency in reporting statistical values and terminology A quick check of PCR conditions (e.g., extension temperature) for clarity ********** -->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. --> |
| Revision 2 |
|
-->PONE-D-25-54696R2-->-->Elevation and land use shape soil entomopathogenic fungal communities in the Uluguru mountains, Tanzania: Insights from metagenomic and culture-based approaches-->-->PLOS One Dear Dr. Mussa,-->--> Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 28 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
--> If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Ebrahim Shokoohi Academic Editor PLOS One Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: The paper improved by addressing the concerns raised by the reviewers. However, some critical point still lacking, which should be addressed. The authors must include the Bio project and SRA numbers of the sequences into the manuscript at the materials and methods, where relevant. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. --> |
| Revision 3 |
|
Elevation and land use shape soil entomopathogenic fungal communities in the Uluguru mountains, Tanzania: Insights from metagenomic and culture-based approaches PONE-D-25-54696R3 Dear Dr. Abel Jonathan Mussa, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ebrahim Shokoohi Academic Editor PLOS One Additional Editor Comments (optional): The authors addressed all raised questions, and improved the paper. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-54696R3 PLOS One Dear Dr. Mussa, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ebrahim Shokoohi Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .